bpc-157 empty stomach or with food absorption Delayed BPC - 157 With or

AN: Methodology, Investigation, Writing review and editing

The incidence of oliguria is reported as less than 1% with systemic ketorolac or other NSAID use

Interaction risks with medicines or other research compounds are unknown

These peptides are known from WO 94/11394 and WO 93/24521, whose contents are incorporated in the present disclosure with respect to the preparation and use of the BPC peptides

10.1007/s10620-014-3097-3 Summary Keywords functional dyspepsia, gastroparesis, gastrointestinal peptides, cholecystokinin, glucagonlike peptide 1, peptide YY, motilin, ghrelin Citation Van den Houte K, Scarpellini E, Verbeure W, Mori H, Schol J, Masuy I, Carbone F and Tack J (2020) The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review

It demonstrates notable stability in human gastric juice and systemic activity across multiple administration routes